Transforming Growth Factor-β Promotes Morphomechanical Effects Involved in Epithelial to Mesenchymal Transition in Living Hepatocellular Carcinoma

Mariafrancesca Cascione, Stefano Leporatti, Francesco Dituri, Gianluigi Giannelli

Research output: Contribution to journalArticle

Abstract

The epithelial mesenchymal transition (EMT) is a physiological multistep process involving epithelial cells acquiring a mesenchymal-like phenotype. It is widely demonstrated that EMT is linked to tumor progression and metastasis. The transforming growth factor (TGF)-β pathways have been widely investigated, but its role in the hepatocarcinoma EMT is still unclear. While the biochemical pathways have been extensively studied, the alteration of biomechanical behavior correlated to cellular phenotype and motility is not yet fully understood. To better define the involvement of TGF-β1 in the metastatic progression process in different hepatocarcinoma cell lines (HepG2, PLC/PRF/5, HLE), we applied a systematic morphomechanical approach in order to investigate the physical and the structural characteristics. In addition, we evaluated the antitumor effect of LY2157299, a TGF-βR1 kinase inhibitor, from a biomechanical point of view, using Atomic Force and Confocal Microscopy. Our approach allows for validation of biological data, therefore it may be used in the future as a diagnostic tool to be combined with conventional biomolecular techniques.

Original languageEnglish
JournalInternational Journal of Molecular Sciences
Volume20
Issue number1
DOIs
Publication statusPublished - Dec 28 2018

Fingerprint

Epithelial-Mesenchymal Transition
Transforming Growth Factors
Hepatocellular Carcinoma
phenotype
cancer
LY-2157299
progressions
Physiological Phenomena
Phenotype
locomotion
Confocal microscopy
Atomic Force Microscopy
metastasis
Programmable logic controllers
cultured cells
Confocal Microscopy
inhibitors
Tumors
Atomic force microscopy
Phosphotransferases

Keywords

  • Biomarkers
  • Carcinoma, Hepatocellular/etiology
  • Cell Line, Tumor
  • Cell Transformation, Neoplastic/metabolism
  • Cytoskeleton/metabolism
  • Elastic Modulus
  • Epithelial-Mesenchymal Transition
  • Humans
  • Liver Neoplasms/etiology
  • Mechanotransduction, Cellular
  • Microscopy, Atomic Force
  • Neoplasm Grading
  • Transforming Growth Factor beta/metabolism

Cite this

@article{7121e7ce3e3a4930b3fff47644ade202,
title = "Transforming Growth Factor-β Promotes Morphomechanical Effects Involved in Epithelial to Mesenchymal Transition in Living Hepatocellular Carcinoma",
abstract = "The epithelial mesenchymal transition (EMT) is a physiological multistep process involving epithelial cells acquiring a mesenchymal-like phenotype. It is widely demonstrated that EMT is linked to tumor progression and metastasis. The transforming growth factor (TGF)-β pathways have been widely investigated, but its role in the hepatocarcinoma EMT is still unclear. While the biochemical pathways have been extensively studied, the alteration of biomechanical behavior correlated to cellular phenotype and motility is not yet fully understood. To better define the involvement of TGF-β1 in the metastatic progression process in different hepatocarcinoma cell lines (HepG2, PLC/PRF/5, HLE), we applied a systematic morphomechanical approach in order to investigate the physical and the structural characteristics. In addition, we evaluated the antitumor effect of LY2157299, a TGF-βR1 kinase inhibitor, from a biomechanical point of view, using Atomic Force and Confocal Microscopy. Our approach allows for validation of biological data, therefore it may be used in the future as a diagnostic tool to be combined with conventional biomolecular techniques.",
keywords = "Biomarkers, Carcinoma, Hepatocellular/etiology, Cell Line, Tumor, Cell Transformation, Neoplastic/metabolism, Cytoskeleton/metabolism, Elastic Modulus, Epithelial-Mesenchymal Transition, Humans, Liver Neoplasms/etiology, Mechanotransduction, Cellular, Microscopy, Atomic Force, Neoplasm Grading, Transforming Growth Factor beta/metabolism",
author = "Mariafrancesca Cascione and Stefano Leporatti and Francesco Dituri and Gianluigi Giannelli",
year = "2018",
month = "12",
day = "28",
doi = "10.3390/ijms20010108",
language = "English",
volume = "20",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "MDPI AG",
number = "1",

}

TY - JOUR

T1 - Transforming Growth Factor-β Promotes Morphomechanical Effects Involved in Epithelial to Mesenchymal Transition in Living Hepatocellular Carcinoma

AU - Cascione, Mariafrancesca

AU - Leporatti, Stefano

AU - Dituri, Francesco

AU - Giannelli, Gianluigi

PY - 2018/12/28

Y1 - 2018/12/28

N2 - The epithelial mesenchymal transition (EMT) is a physiological multistep process involving epithelial cells acquiring a mesenchymal-like phenotype. It is widely demonstrated that EMT is linked to tumor progression and metastasis. The transforming growth factor (TGF)-β pathways have been widely investigated, but its role in the hepatocarcinoma EMT is still unclear. While the biochemical pathways have been extensively studied, the alteration of biomechanical behavior correlated to cellular phenotype and motility is not yet fully understood. To better define the involvement of TGF-β1 in the metastatic progression process in different hepatocarcinoma cell lines (HepG2, PLC/PRF/5, HLE), we applied a systematic morphomechanical approach in order to investigate the physical and the structural characteristics. In addition, we evaluated the antitumor effect of LY2157299, a TGF-βR1 kinase inhibitor, from a biomechanical point of view, using Atomic Force and Confocal Microscopy. Our approach allows for validation of biological data, therefore it may be used in the future as a diagnostic tool to be combined with conventional biomolecular techniques.

AB - The epithelial mesenchymal transition (EMT) is a physiological multistep process involving epithelial cells acquiring a mesenchymal-like phenotype. It is widely demonstrated that EMT is linked to tumor progression and metastasis. The transforming growth factor (TGF)-β pathways have been widely investigated, but its role in the hepatocarcinoma EMT is still unclear. While the biochemical pathways have been extensively studied, the alteration of biomechanical behavior correlated to cellular phenotype and motility is not yet fully understood. To better define the involvement of TGF-β1 in the metastatic progression process in different hepatocarcinoma cell lines (HepG2, PLC/PRF/5, HLE), we applied a systematic morphomechanical approach in order to investigate the physical and the structural characteristics. In addition, we evaluated the antitumor effect of LY2157299, a TGF-βR1 kinase inhibitor, from a biomechanical point of view, using Atomic Force and Confocal Microscopy. Our approach allows for validation of biological data, therefore it may be used in the future as a diagnostic tool to be combined with conventional biomolecular techniques.

KW - Biomarkers

KW - Carcinoma, Hepatocellular/etiology

KW - Cell Line, Tumor

KW - Cell Transformation, Neoplastic/metabolism

KW - Cytoskeleton/metabolism

KW - Elastic Modulus

KW - Epithelial-Mesenchymal Transition

KW - Humans

KW - Liver Neoplasms/etiology

KW - Mechanotransduction, Cellular

KW - Microscopy, Atomic Force

KW - Neoplasm Grading

KW - Transforming Growth Factor beta/metabolism

U2 - 10.3390/ijms20010108

DO - 10.3390/ijms20010108

M3 - Article

C2 - 30597907

VL - 20

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 1

ER -